Management of Knee Osteoarthritis What Internists Need to

被引:13
作者
Block, Joel A. [1 ]
Cherny, Dmitriy [1 ]
机构
[1] Rush Univ, Div Rheumatol, Med Ctr, 1611 West Harrison St,Suite 510, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
Osteoarthritis; Knee pain; Nerve growth factor; Placebo effect; Platelet rich plasma; PLATELET-RICH PLASMA; INTRAARTICULAR INJECTION; RHEUMATOID-ARTHRITIS; CONTROLLED-TRIAL; PAIN; EFFICACY; TANEZUMAB; SAFETY; RISK; HIP;
D O I
10.1016/j.mcna.2020.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Knee osteoarthritis (OA) is a common and morbid condition. No disease-modifying therapies exist; hence the goals of current treatment are to palliate pain and to retain function. OA is significantly influenced by the placebo effect. Nonpharmacologic interventions are essential and have been shown to improve outcomes. Canes, unloading braces, and therapeutic heating/cooling may be valuable. Pharmacotherapy options include topical and oral nonsteroidal anti-inflammatory drugs, duloxetine, and periodic intra-articular glucocorticoids and hyaluronans. Opioids, intra-articular stem cells, and platelet-rich plasma are not recommended. Novel targets such as nerve growth factor are under investigation and may be approved soon for OA pain. © 2020 Elsevier Inc.
引用
收藏
页码:367 / 385
页数:19
相关论文
共 50 条
  • [41] Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence
    Fazeli, Mir Sohail
    McIntyre, Louis
    Huang, Yili
    Chevalier, Xavier
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [42] Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee
    Kanchanatawan, Wichan
    Arirachakaran, Alisara
    Chaijenkij, Kornkit
    Prasathaporn, Niti
    Boonard, Manusak
    Piyapittayanun, Peerapong
    Kongtharvonskul, Jatupon
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2016, 24 (05) : 1665 - 1677
  • [43] Alternatives to Biologics in Management of Knee Osteoarthritis: A Systematic Review
    Hassan, Fadi
    Murrell, William D.
    Refalo, Andrew
    Maffulli, Nicola
    SPORTS MEDICINE AND ARTHROSCOPY REVIEW, 2018, 26 (02) : 79 - 85
  • [44] Topical therapies for knee osteoarthritis
    Rodriguez-Merchan, E. C.
    POSTGRADUATE MEDICINE, 2018, 130 (07) : 607 - 612
  • [45] Elaboration and validation of a questionnaire assessing patient expectations about management of knee osteoarthritis by their physicians: the Knee Osteoarthritis Expectations Questionnaire
    Benhamou, Mathilde
    Boutron, Isabelle
    Dalichampt, Marie
    Baron, Gabriel
    Alami, Sophie
    Rannou, Francois
    Ravaud, Philippe
    Poiraudeau, Serge
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 552 - 559
  • [46] Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
    Honvo, Germain
    Bruyere, Olivier
    Reginster, Jean-Yves
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (08) : 1163 - 1167
  • [47] Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial
    Rai, Shivam
    Patel, Sandeep
    Chouhan, Devendra Kumar
    Jain, Ashish
    Thami, Tarkik
    Dadra, Ankit
    Dhillon, Mandeep Singh
    INDIAN JOURNAL OF ORTHOPAEDICS, 2024, 58 (07) : 905 - 913
  • [48] Intra-articular Therapies for Knee Osteoarthritis: Current Update
    Oo, Win Min
    Hunter, J.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2023, 9 (03) : 99 - 119
  • [49] Biologic Therapies for the Treatment of Knee Osteoarthritis: An Updated Systematic Review
    Delanois, Ronald E.
    Sax, Oliver C.
    Chen, Zhongming
    Cohen, Jacob M.
    Callahan, Daniel M.
    Mont, Michael A.
    JOURNAL OF ARTHROPLASTY, 2022, 37 (12) : 2480 - 2506